DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr | ₹-1,091 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-799 Cr |
Mar2023 | ₹-797 Cr |
Mar2022 | ₹-532 Cr |
Mar2021 | ₹-35 Cr |
Mar2020 | ₹-1,091 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹-797 Cr | Negative | |
Mar2022 | ₹-532 Cr | Negative | |
Mar2021 | ₹-35 Cr | Negative | |
Mar2020 | ₹-1,091 Cr | - |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹152,628.0 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,223.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
CIPLA | ₹119,067.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹102,744.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,123.8 Cr | -4% | -5.9% | -7.8% | Stock Analytics | |
MANKIND PHARMA | ₹95,998.8 Cr | -0.8% | -7.2% | 7.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.9% |
-0.3% |
63.8% |
SENSEX | -0.8% |
-1.6% |
3.1% |
You may also like the below Video Courses